An Illinois startup has developed AI-powered imaging technology for breast cancer surgery, creating 3D tumour models from MRIs to aid surgical planning. The FDA-cleared technology provides colour-coded visualisations and key measurements, helping surgeons decide between breast conservation and mastectomy. The company is also developing AI to convert patient positioning in images and quickly assess cancer recurrence risk, potentially reducing treatment planning time significantly.
